The Latest in Type 2 Diabetes ICYMI

T2D: Increased risk for ventricular arrhythmia or sudden cardiac death with sulfonylurea vs metformin

October 23, 2022

Diabetes

Antidiabetic drugs influence fracture risk in T2D

October 23, 2022

Diabetes

Tirzepatide vs. insulin glargine improves renal outcomes in T2D

October 23, 2022

Diabetes

Yoga and other mind-body work good for diabetes control

October 21, 2022

Diabetes

Drug repurposing ‘fast track’ to new medicines for obesity, diabetes

October 20, 2022

Diabetes

Insulin rationing common, ‘surprising’ even among privately insured

October 19, 2022

Diabetes

Diabetes becoming less potent risk factor for CVD events

October 19, 2022

Diabetes

Finerenone benefits T2D across spectrum of renal function

October 18, 2022

Diabetes

Tirzepatide’s benefits expand: Lean mass up, serum lipids down

October 13, 2022

Diabetes

New advice on artificial pancreas insulin delivery systems

October 12, 2022

Diabetes

Dapagliflozin DELIVERs regardless of systolic pressure in HFpEF

October 11, 2022

Diabetes

Bariatric surgery prompts visceral fat reduction, cardiac changes

October 10, 2022

Diabetes

Type 2 Diabetes in Adolescents: We Must Do Better

October 10, 2022

Diabetes

Newer drugs not cost effective for first-line diabetes therapy

October 6, 2022

Diabetes

Food insecurity a growing problem for many with CVD

October 5, 2022

Diabetes